Personalised Management of Prostate Cancer

Personalised Management of Prostate Cancer

Despite recent advances, prostate cancer continues to be a leading cause of cancer-related death among men. While the standard management options of surgery, radiotherapy, and androgen deprivation therapy are well established, there are still significant unmet needs. For example, which patients woul...

Full description

Bibliographic Details
Main Authors: Dilip Babu, Deepak Sahasrabudhe
Format: Article
Language:English
Published: European Medical Journal 2018-06-01
Series:European Medical Journal Urology
Subjects:
Circulating tumour cells (CTC)
multigene assay
personalised medicine
poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors
prostate cancer
risk stratification
Online Access:https://www.emjreviews.com/urology/article/personalised-management-of-prostate-cancer/

Internet

https://www.emjreviews.com/urology/article/personalised-management-of-prostate-cancer/

Similar Items